Pharmaceutical & Life Sciences News

Promoting Unapproved Drug Uses (Still) Not Free Speech

Dec. 3, 2018, 11:15 AM

Misleading investors and the public about science is as serious as misstating financial information, life science company executives should know—now that a convicted drug-company ex-CEO has lost his last court appeal.

InterMune Inc. founder Dr. W. Scott Harkonen was convicted in 2009 of wire fraud for his role in creating and disseminating a press release publicizing the use of a drug to treat fatal lung disease that the drug wasn’t approved to treat. The U.S. Supreme Court again Nov. 5 refused to consider his case. It was the second time justices declined to review his appeal.

“If there is a...

To read the full article log in. To learn more about a subscription click here.